← US Feed

Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study

AI Briefing

  • Theralase(R) Reports Positive Results from Preclinical Study
  • X-Ray-Activated Rutherrin(R) Shows Potential to Treat Muscle Invasive Bladder Cancer
  • Company to Pursue Regulatory Approvals for Potential New Cancer Therapy
Advertisement
Read Original Article